Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season

Ding, Helen; Black, Carla L.; Ball, Sarah; Fink, Rebecca V.; Williams, Walter W.; Fiebelkorn, Amy Parker; Lu, Peng–jun; Kahn, Katherine E.; D’Angelo, Denise V.; Devlin, Rebecca; Greby, Stacie M.

doi:10.15585/mmwr.mm6638a2

Cited by 111 publications

(117 citation statements)

References 9 publications

Supporting

Mentioning

105

Contrasting

Order By: Relevance

“…Whether this estimation reflects a real increase in seasonal coverage rate is not clear and should be confirmed in a larger sample. However, it may reflect the progressive implementation of the 2012-recommendation, like previously reported in the Unites States, where the influenza vaccine coverage rose from 20% before in 2008/2009 to approximately 50% for the 2013/2014 season [34,35]. This rate is nevertheless below the recommended level (100%), as also reported in four other European countries in 2010/2011 [36].…”

Section: Discussionsupporting

confidence: 60%

“…In pregnant women and women who plan a pregnancy, several web-based studies have already been undertaken, mainly focusing on pre-conception risk factors for adverse pregnancy outcomes [43][44][45][46][47]. Regarding influenza, only one annual transversal web-based survey is conducted each year since 2010/2011 in the USA to assess vaccination coverage among pregnant women [35,48].…”

Section: Discussionmentioning

confidence: 99%

“…This rate was higher in women older than 40 years (RR = 3.0, 95%CI [1.1-8.3], p = 0.03) and during first/second trimesters compared to third trimester (RR = 4.0, 95%CI [1.4-12.0], p = 0.01). Crude vaccination coverage was 39% (95%CI, [31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47] and weighted vaccination coverage was estimated at 26% (95%CI, [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]. Health care provider recommendation for vaccination (corrected OR = 7.8; 95%CI [3.0-17.1]) and non-smoking status (cOR = 2.1; 95%CI [1.2-6.9]) were associated with higher vaccine uptake.…”

Section: B S T R a C Tmentioning

confidence: 99%

See 2 more Smart Citations

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet

Loubet

Guerrisi

Turbelin

et al. 2016

Vaccine

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 60%

Section: Discussionmentioning

confidence: 99%

Section: B S T R a C Tmentioning

confidence: 99%

See 1 more Smart Citation

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet

Loubet

Guerrisi

Turbelin

et al. 2016

Vaccine

View full text Add to dashboard Cite

“…Maternal influenza vaccination rates in the United States have now risen to approximately 50% and were somewhat higher during the H1N1 pandemic. 18 High rates of pertussis vaccination during pregnancy (in excess of 70%) were achieved in the United Kingdom after the program was implemented in response to an increase in neonatal pertussis deaths. 19 Similar success has not been achieved in the United States, where rates have been estimated to be below 5% despite 5 y of a maternal immunization recommendation.…”

Section: Introductionmentioning

confidence: 99%

Improving rates of maternal immunization: Challenges and opportunities

MacDougall

Halperin

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Objectives: An increasing number of vaccines are recommended or are being developed for use during pregnancy to protect women, fetuses, and/or newborns. For vaccines that are already recommended, vaccine uptake is variable and well below desired target. We reviewed the literature related to factors that affect a healthcare provider's recommendation and a woman's willingness to be vaccinated during pregnancy. Design: A scoping review of published literature from 2005 to 2015 was undertaken and all relevant articles were abstracted, summarized, and organized thematically. Results: Barriers and facilitators were identified that either decreased or increased the likelihood of a healthcare provider offering and a pregnant woman accepting vaccination during pregnancy. Concern about the safety of vaccines given during pregnancy was the most often cited barrier among both the public and healthcare providers. Other barriers included doubt about the effectiveness of the vaccine, lack of knowledge about the burden of disease, and not feeling oneself to be at risk of the infection. Major facilitators for maternal immunization included specific safety information about the vaccine in pregnant women, strong national recommendations, and healthcare providers who both recommended and provided the vaccine to their patients. Systems barriers such as inadequate facilities and staffing, vaccine purchase and storage, and reimbursement for vaccination were also cited. Evidence-based interventions were few, and included text messaging reminders, chart reminders, and standing orders. Conclusions: In order to have an effective vaccination program, improvements in the uptake of recommended vaccines during pregnancy are needed. A maternal immunization platform is required that normalizes vaccination practice among obstetrical care providers and is supported by basic and continuing education, communication strategy, and a broad range of research.

show abstract

“…Similar to national data, many practices are not following current ACIP recommendations. 15,16 However, immunization delivery in OB/ GYN settings is a relatively new paradigm. Prior to the 2009 influenza pandemic, few OB/GYN practices delivered influenza vaccine, with national rates from 11 to 35% for influenza vaccine in pregnancy in the prior decade.…”

Section: Discussionmentioning

confidence: 99%

Evidence-based vaccination strategies in obstetrics and gynecology settings: Current practices and methods for assessment

O’Leary

Pyrzanowski

Brewer

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Obstetrician-gynecologists have the potential to play an important role in the delivery of immunizations to women. However, despite national recommendations, immunization rates among pregnant women and adults in general remain low. Pragmatic immunization delivery trials are needed to demonstrate how best to deliver vaccines in such settings. We report the development and implementation of 2 novel methodologies for immunization delivery research and quality improvement in such settings. The first was the development and application of a 47-point Immunization Delivery Scale that formally assessed variability among practices in their engagement in a variety of evidence-based practices for improving immunization rates. The second was a covariate-constrained randomization technique -a method for achieving balance between study arms in cluster-randomized trials that is especially applicable to pragmatic trials.. To best achieve meaningful and interpretable findings, we recommend use of these or similar techniques in future immunization research and quality improvement projects in OB/GYN settings.

show abstract

Influenza Vaccination Coverage Among Pregnant Women — United States, 2016–17 Influenza Season

Cited by 111 publications

References 9 publications

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet

Improving rates of maternal immunization: Challenges and opportunities

Evidence-based vaccination strategies in obstetrics and gynecology settings: Current practices and methods for assessment

Contact Info

Product

Resources

About